BioNTech SE (VIE:BNTX)
73.70
-1.35 (-1.80%)
At close: Nov 20, 2026
BioNTech SE Revenue
BioNTech SE had revenue of 1.32B EUR in the quarter ending September 30, 2026, a decrease of -14.62%. This brings the company's total for the last twelve months to 2.55B, up 1,160.29% year-over-year. In the year 2025, BioNTech SE had annual revenue of 3.05B with 5.63% growth.
Revenue (ttm)
2.55B
Revenue Growth
+1,160.29%
P/S Ratio
7.55
Revenue / Employee
310.02K
Employees
7,807
Market Cap
18.28B
Revenue by Segment
Fiscal year ended Dec 31, 2025 See the full BioNTech SE breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.05B | 162.80M | 5.63% |
| Dec 31, 2024 | 2.89B | -1.03B | -26.31% |
| Dec 31, 2023 | 3.92B | -13.39B | -77.33% |
| Dec 31, 2022 | 17.31B | -1.67B | -8.78% |
| Dec 31, 2021 | 18.98B | 18.49B | 3,834.63% |
| Dec 31, 2020 | 482.30M | 373.70M | 344.11% |
| Dec 31, 2019 | 108.60M | -18.98M | -14.87% |
| Dec 31, 2018 | 127.58M | 65.98M | 107.11% |
| Dec 31, 2017 | 61.60M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| OMV Aktiengesellschaft | 28.22B |
| Strabag SE | 19.91B |
| Vienna Insurance Group AG | 14.40B |
| Erste Group Bank AG | 14.21B |
| Raiffeisen Bank International AG | 8.92B |
| Andritz AG | 8.25B |
| VERBUND AG | 7.72B |
| Telekom Austria AG | 5.65B |
BioNTech SE News
- 3 days ago - BioNTech price target raised to $93 from $92 at JPMorgan - TheFly
- 9 days ago - BioNTech May Be the Next Moderna. Even if it Isn't, the Stock Is a Buy. - Barrons
- 13 days ago - BioNTech price target lowered to $110 from $130 at H.C. Wainwright - TheFly
- 18 days ago - BioNTech price target lowered to $106 from $114 at Morgan Stanley - TheFly
- 18 days ago - BioNTech price target lowered to $108 from $114 at BofA - TheFly
- 18 days ago - BioNTech price target lowered to $125 from $135 at UBS - TheFly
- 19 days ago - BioNTech SE Earnings Call Transcript: Q3 2026 - Transcripts
- 19 days ago - BioNTech SE Earnings release: Q3 2026 - Filings